|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||3.27|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
U.S. Marijuana Index, compiled by Marijuana International Corporation, has delivered 158% returns over the past one year, as of October 17, 2018. Though the market saw a lot of volatility in marijuana policy during the course of the year on account of hard line policy stance taken by the new U.
A permissive medical marijuana law received voter approval in Oklahoma earlier this year. Also, Republicans in Texas recently approved medical marijuana in their party platform. When this status changes, investing in medically-related marijuana stocks could reach a fever pitch in the fourth quarter and beyond.
Up to this point, cannabis stocks have been trendy and red-hot thanks to global progress toward regulations that legalize weed. As such, cannabis stocks had their day in the sun, but that day is over. The Canada Marijuana Stock Index is actually more than 50% off its 2018 highs.
MariMed's share price has nearly quadrupled so far in 2018. Here's why -- and whether the hot marijuana stock is one to buy.
Aurora Cannabis Inc (OTC: ACBFF) received conditional approval from Malta Enterprise to establish a seed-to-pharma cannabis operation. “Aurora already was the first company to export medical cannabis to both Italy and Malta, and now are the first to receive approval for the production, processing, and distribution of cannabis in the country,” Neil Belot, Aurora’s chief global business development officer, said in a statement.